Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients

Antzeko izenburuak

• Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals
  nork: Lagler, Heimo, et al.
  Argitaratua: (2012)
• Comparison of immunogenicity of a whole virion and a subunit influenza vaccine in adults.
  nork: Ortbals, D W, et al.
  Argitaratua: (1978)
• Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
  nork: Uraki, Ryuta, et al.
  Argitaratua: (2014)
• Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines
  nork: Allegra Peletta, et al.
  Argitaratua: (2024-07-01)
• Long-Term Immunogenicity of an Inactivated Split-Virion 2009 Pandemic Influenza A H1N1 Virus Vaccine with or without Aluminum Adjuvant in Mice
  nork: Xu, Wenting, et al.
  Argitaratua: (2015)